IP-10 (CXCL10) Human ProcartaPlex™ Simplex Kit
Invitrogen™

IP-10 (CXCL10) Human ProcartaPlex™ Simplex Kit

Le kit simplex pour IP-10 humaine (CXCL10) ProcartaPlex mesure la protéine IP-10 (CXCL10). Il est conçu pour être utilisé avecAfficher plus
Have Questions?
RéférenceQuantité
EPX01A-10284-90196 dosages
Référence EPX01A-10284-901
Prix (EUR)
349,00
Each
Quantité:
96 dosages
Prix (EUR)
349,00
Each
Le kit simplex pour IP-10 humaine (CXCL10) ProcartaPlex mesure la protéine IP-10 (CXCL10). Il est conçu pour être utilisé avec d’autres kits simplex afin que vous puissiez créer votre propre panneau multiplex faisant appel à la technologie Luminex xMAP pour détecter / quantifier des protéines. Lors de l’association de plusieurs kits Simplex (c.-à-d., lorsque vous n’utilisez pas de panneau multiplex préconfiguré), un seul kit de tampon (vendu séparément) est nécessaire pour chaque plaque de dosage, quelle que soit la taille du plex.

À propos des dosages ProcartaPlex pour la plateforme Luminex

Les immunodosages ProcartaPlex sont basés sur les principes du dosage ELISA sandwich, utilisant deux anticorps hautement spécifiques se liant à différents épitopes d’une protéine pour quantifier simultanément toutes les cibles protéiques à l’aide d’un instrument Luminex. Les dosages multiplex ProcartaPlex nécessitent seulement seulement 25 µl de plasma ou de sérum, ou 50  µl de surnageant de culture cellulaire, et seulement quatre heures pour obtenir les résultats analysés.

Plus de résultats par échantillon :mesure plusieurs cibles protéiques simultanément dans un seul échantillon de 25 à 50 µl

Technologie Luminex largement utilisée :plateforme de multiplexage hautement référencée pour la détection et la quantification des protéines

Les dosages ProcartaPlex utilisent la technologie Luminex xMAP (profilage multi-analytes) pour la détection et la quantification simultanées de 80 cibles protéiques maximum dans un échantillon unique de 25 à 50 µl provenant de plasma, de sérum, de surnageants de cultures cellulaires et d’autres liquides corporels.

Les microbilles Luminex dans le dosage ProcartaPlex sont colorées en interne avec des fluorophores rouges et infrarouges de proportions précises afin de créer des signatures spectrales spécifiques pouvant être identifiées par les systèmes de détection Luminex xMAP (p. ex., Luminex 200, FLEXMAP 3D et MAGPIX). Comme le dosage ELISA sandwich, le dosage ProcartaPlex utilise des paires d’anticorps appariées pour identifier la protéine d’intérêt. Dans un dosage multiplex, chaque microbille unique d’un point de vue spectral est marquée avec des anticorps spécifiques pour une protéine cible unique. Les protéines liées sont identifiées à l’aide d’anticorps biotinylés et de la streptavidine-R-phycoérythrine (RPE). La conjugaison d’anticorps spécifiques d'une protéine à une microbille distincte permet d’analyser plusieurs cibles dans un seul puits.

La différence la plus significative entre un dosage ProcartaPlex et un dosage ELISA est que l’anticorps de capture du dosage ProcartaPlex est conjugué à une microbille et n’est pas adsorbé par un des puits de la microplaque. Ainsi, les réactifs de dosage ProcartaPlex flottent librement dans la solution. Pour la détection, l’instrument Luminex 200, par exemple, contient deux lasers : un pour distinguer la signature spectrale de chaque microbille et un autre pour quantifier la quantité de fluorescence de la RPE. Cette dernière est proportionnelle à la quantité de protéine présente dans l’échantillon. Les dosages multiplex ProcartaPlex peuvent profiler plus de protéines cibles à l’aide d’un échantillon nettement moins important. Cela leur prend autant de temps que pour effectuer un dosage ELISA sandwich traditionnel.

Les panneaux multiplex ProcartaPlex sont disponibles en plusieurs formats et peuvent être utilisés sur six espèces (humain, souris, rat, primate non humain, porcin et canin). Rendez-vous sur le site thermofisher.com/procartaplex pour obtenir davantage d’informations. Vous y trouverez notamment une liste complète des cibles protéiques individuelles.
Usage exclusivement réservé à la recherche. Ne pas utiliser pour des procédures de diagnostic.
Spécifications
Plage de dosageAs determined for Lot 1: 1.95 - 8000 pg/mL
Sensibilité du dosageAs determined for Lot 1: 0.3 pg/mL
Type de microbillesIP-10 (CXCL10) [22]
À utiliser avec (équipement)Instruments Luminex™
FormatKit simplex
ExpressionC-X-C motif chemokine ligand 10
Alias de gèneC7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1
Identification génétique (Entrez)3627
Symbole de gène(s)CXCL10
Gamme de produitsProcartaPlex
ProtéineC-X-C motif chemokine 10
Sous-type de protéineprotéine induite par l’interféron gamma de 10 kDa, gamma-IP10, IP-10, cytokine B10 peu inductible
Type d’échantillonSérum, plasma, surnageants de culture cellulaire (SCC)
Volume d’échantillonSérum, plasma : 25 μl ; CCS : 50 μl
Conditions d’expéditionWet Ice
ID UniProtP02778
CombinabilityCombinable
Type de produitKit simplex
Quantité96 dosages
Research AreaImmunology, Oncology, Neurobiology, Toxicology, Chemokines
EspècesHumaine
Unit SizeEach
Contenu et stockage
• 1 flacon de microbilles de capture (50X)
• 1 flacon d’anticorps de détection biotinylés (50X)
• 2 flacons d’un mélange d’étalons pour humain B (lyophilisé)

Stockage entre 2 et 8°C.

Foire aux questions (FAQ)

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Citations et références (10)

Citations et références
Abstract
Impaired efferocytosis by monocytes in multiple myeloma.
Authors:Liang YY, Schwarzinger I, Simonitsch-Klupp I, Agis H, Oehler R
Journal:Oncol Lett
PubMed ID:29928429
'Efficient clearance of apoptotic cells by efferocytosis is important for tissue homeostasis. Impaired efferocytosis leads to the accumulation of cell debris, which is regarded as a trigger in chronic inflammation and autoimmune diseases. Patients with hematological neoplastic disorders such as multiple myeloma (MM) exhibit high blood levels of apoptotic microparticles. ... More
Corticosteroids and infliximab impair the performance of interferon-? release assays used for diagnosis of latent tuberculosis.
Authors:Edwards A, Gao Y, Allan RN, Ball D, de Graaf H, Coelho T, Clifford V, Curtis N, Williams A, Faust SN, Mansour S, Marshall B, Elkington P, Tebruegge M
Journal:Thorax
PubMed ID:28159773
'The impact of immunosuppression on interferon-? release assays and novel cytokine biomarkers of TB infection, mycobacteria-specific IL-2, IP-10 and TNF-a responses was investigated in an ex vivo model. Cytokine responses in standard QuantiFERON-TB Gold in-Tube (QFT-GIT) assays were compared with duplicate assays containing dexamethasone or infliximab. Dexamethasone converted QFT-GIT results ... More
Loss of TNFAIP3 enhances MYD88
Authors:Wenzl K, Manske MK, Sarangi V, Asmann YW, Greipp PT, Schoon HR, Braggio E, Maurer MJ, Feldman AL, Witzig TE, Slager SL, Ansell SM, Cerhan JR, Novak AJ
Journal:Blood Cancer J
PubMed ID:30301877
'MYD88 mutations are one of the most recurrent mutations in hematologic malignancies. However, recent mouse models suggest that MYD88'
The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
Authors:Matz M, Lorkowski C, Fabritius K, Wu K, Rudolph B, Frischbutter S, Brakemeier S, Gaedeke J, Neumayer HH, Mashreghi MF, Budde K
Journal:Transpl Immunol
PubMed ID:27693310
'Cellular and antibody-mediated rejection processes and also interstitial fibrosis/tubular atrophy (IFTA) lead to allograft dysfunction and loss. The search for accurate, specific and non-invasive diagnostic tools is still ongoing and essential for successful treatment of renal transplanted patients. Molecular markers in blood cells and serum may serve as diagnostic tools ... More
Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Authors:Liba Z, Kayserova J, Elisak M, Marusic P, Nohejlova H, Hanzalova J, Komarek V, Sediva A
Journal:J Neuroinflammation
PubMed ID:26941012
'Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance. There are limited data regarding T cell involvement in the disease. To contribute to the ... More